RDZNRoadzen Inc.

Nasdaq www.roadzen.io


$ 2.94 $ 1.33 (82.1 %)    

Tuesday, 02-Jul-2024 15:59:49 EDT
QQQ $ 486.52 $ 5.06 (1.05 %)
DIA $ 393.25 $ 1.83 (0.47 %)
SPY $ 548.30 $ 3.67 (0.67 %)
TLT $ 90.61 $ 0.70 (0.78 %)
GLD $ 215.57 $ -0.01 (0 %)
$ 2.95
$ 2.32
$ 0.00 x 0
$ 0.00 x 0
$ 2.10 - $ 3.27
$ 1.55 - $ 14.10
107,164,065
na
129.9M
$ 0.30
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-01-2024 03-31-2024 10-K
2 02-12-2024 12-31-2023 10-Q
3 11-13-2023 09-30-2023 10-Q
4 08-16-2023 06-30-2023 10-Q
5 05-19-2023 03-31-2023 10-Q
6 04-14-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stocks-hold-steady-as-powell-reassures-on-disinflation-path-warns-about-debt-risks-tesla-rallies-job-openings-spike-whats-driving-markets-tuesday

U.S. equities were little moved on Tuesday as investors continued to assess the potential for interest rate cuts following the ...

 why-insurance-technology-company-roadzen-shares-are-gaining-today

Roadzen reported robust revenue growth for fiscal year 2024 and inclusion in Russell indexes.

Core News & Articles
Market-Moving News for July 2nd
07/02/2024 12:29:43

RDZN: 81% | Roadzen shares are trading higher following FY24 earnings. RCM: -10% | R1 RCM shares are trading lower after the c...

 maxim-group-initiates-coverage-on-roadzen-with-buy-rating-announces-price-target-of-10

Maxim Group analyst Allen Klee initiates coverage on Roadzen (NASDAQ:RDZN) with a Buy rating and announces Price Target of $10.

 dalmia-transport-selects-roadzens-drivebuddyai-to-enhance-fleet-safety-with-advanced-computer-vision-in-5-year-partnership

Roadzen Inc. (Nasdaq: RDZN) ("Roadzen" or the "Company"), a global leader in AI at the convergence of insurance...

 marinus-pharmaceuticals-neumora-therapeutics-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday.